This inventor holds 1 USPTO granted patent. Top assignee: Exelixis, Inc.. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Michael Christopher Ellis: Innovator in Presenilin Enhancers
Introduction
Michael Christopher Ellis is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of biopharmaceuticals, particularly through his innovative work on presenilin enhancers.
Latest Patents
Ellis holds a patent for "Presenilin enhancers assays." This invention provides methods and compositions related to pen polypeptides that possess pen-specific structure and activity. The patent includes isolated pen hybridization probes and primers that can specifically hybridize with natural pen genes. It also covers pen-specific binding agents, such as specific antibodies, and outlines methods for using these compositions in diagnosis, therapy, and the biopharmaceutical industry.
Career Highlights
Michael Christopher Ellis is currently associated with Exelixis, Inc., where he continues to advance his research and development efforts. His work has implications for genetic hybridization screens and therapeutic applications, particularly in modulating APP processing.
Collaborations
Ellis has collaborated with notable colleagues, including Daniel Tim Curtis and George Ross Francis, contributing to a dynamic research environment that fosters innovation.
Conclusion
Michael Christopher Ellis is a distinguished inventor whose work on presenilin enhancers has the potential to impact the biopharmaceutical industry significantly. His contributions reflect a commitment to advancing scientific knowledge and therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile